LivaNova (LIVN) Common Equity (2014 - 2026)
LivaNova (LIVN) reported Common Equity of $1.2 billion for Q1 2026, up 17.12% on a YoY basis from $1.0 billion in Q1 2025, and up 0.94% sequentially from $1.2 billion in Q4 2025.
LivaNova (LIVN) Common Equity (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 13 years of Common Equity data on file, last reported at $1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 17.12% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 17.12% YoY), and the FY2025 full-year result was $1.2 billion, down 9.11% from the prior year.
- Common Equity climbed to $1.2 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.3 billion in Q4 2024 to a low of $1.0 billion in Q1 2025.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 frame the typical range for Common Equity.
- Across the five-year window, Common Equity grew 24.63% in 2022 and decreased 15.33% in 2025, its largest moves.
- Tracing LIVN's Common Equity over 5 years: stood at $1.2 billion in 2022, then climbed by 5.8% to $1.3 billion in 2023, then grew by 3.34% to $1.3 billion in 2024, then fell by 9.11% to $1.2 billion in 2025, then grew by 0.94% to $1.2 billion in 2026.
- Business Quant data shows LIVN's Common Equity at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Mar 31, 2024 | 1.22 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.29 Bn |
| Sep 30, 2021 | 1.30 Bn |
| Jun 30, 2021 | 1.03 Bn |